Albiflorin

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

白花素和芍药苷对谷氨酸毒性具有神经保护作用。

Albiflorin has anticonvulsant effect for pain relief. Albiflorin and paeoniflorin has neuroprotective action against Glu toxicity. Albiflorin and paeoniflorin significantly ameliorated Glu-induced reduction of cell viability, nuclear and mitochondrial apoptotic alteration, reactive oxygen species accumulation and B-cell lymphoma 2 (Bcl-2)/Bax ratio. Albiflorin can serve as a new chemical marker for the quality control of Paeoniae Radix and the Chinese Pharmacopoeia can be updated, via has similar anti-inflammatory effects to paeoniflorin.

Albiflorin (50-200 μM; pretreated for 3 hours; PC12 cells) treatment significantly ameliorates glutamate (Glu)-induced reduction of cell viability.Albiflorin (100 μM; pretreated for 3 hours; PC12 cells) treatment significantly ameliorates Glu-induced reduction of nuclear and mitochondrial apoptotic alteration, reactive oxygen species accumulation, and B-cell lymphoma 2 (Bcl-2)/Bax ratio. Albiflorin (100 μM; pretreated for 3 hours; PC12 cells) treatment enhances phosphorylation of AKT and its downstream element GSK-3β. Cell Viability Assay Cell Line:PC12 cells Concentration:50 μM, 100 μM, 200 μM Incubation Time:Pretreated for 3 hours Result:Significantly ameliorated Glu-induced reduction of cell viability.Apoptosis AnalysisCell Line:PC12 cells Concentration:100 μM Incubation Time:Pretreated for 3 hours Result:Significantly ameliorated Glu-induced reduction of nuclear and mitochondrial apoptotic alteration.Western Blot Analysis Cell Line:PC12 cells Concentration:100 μM Incubation Time:Pretreated for 3 hours Result:Enhanced phosphorylation of AKT and its downstream element GSK-3β.

Albiflorin (50?mg/kg; intraperitoneal injection; once a day; for 15 days; Wistar rats) treatment significantly increases the paw withdrawal threshold (PWT) on the 11th and 15th day after surgery in rats. Albiflorin could inhibit the activation of p38 MAPK pathway in spinal microglia and subsequent upregulated IL-1β and TNF-α. Albiflorin displays remarkable effects on inhibiting the activation of astrocytes, suppressing the overelevated expression of phosphorylation of c-JNK (p-JNK) in astrocytes, and decreasing the content of chemokine CXCL1 in the spinal cord. Animal Model:Wistar rats (7-week-old; 200-220?g) bearing chronic constriction injury (CCI)Dosage:50?mg/kg Administration:Intraperitoneal injection; once a day; for 15 days Result:Significantly increased the paw withdrawal threshold (PWT) on the 11th and 15th day after surgery.

——

Others

Other Targets

Others

Inflammation/Immunology

——

39011-90-0

480.46

C23H28O11

>98% (HPLC)

DMSO : ≥ 5.1 mg/mL; 10.61 mM

CC12CC(C3CC1(C3(C(=O)O2)COC(=O)C4=CC=CC=C4)OC5C(C(C(C(O5)CO)O)O)O)O

[1-(|A-d-glucopyranosyloxy)-4-hydroxy-6-methyl-8-oxo-7-oxatricyclo[4.3.0.03,9]non-9-yl]methyl benzoate

(-20℃)

With Ice Pack

≥ 2 years